ATE364089T1 - Reagenzien und methoden zum nachweis von erkrankungen der brust - Google Patents

Reagenzien und methoden zum nachweis von erkrankungen der brust

Info

Publication number
ATE364089T1
ATE364089T1 AT97913936T AT97913936T ATE364089T1 AT E364089 T1 ATE364089 T1 AT E364089T1 AT 97913936 T AT97913936 T AT 97913936T AT 97913936 T AT97913936 T AT 97913936T AT E364089 T1 ATE364089 T1 AT E364089T1
Authority
AT
Austria
Prior art keywords
breast
diseases
reagents
methods
useful
Prior art date
Application number
AT97913936T
Other languages
English (en)
Inventor
Patricia Billing-Medel
Maurice Cohen
Tracey Colpitts
Paula Friedman
Julian Gordon
Edward Granados
Steven Hodges
Michael Klass
Jon Kratochvil
Lisa Roberts-Rapp
John Russell
Steven Stroupe
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE364089T1 publication Critical patent/ATE364089T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97913936T 1996-10-31 1997-10-31 Reagenzien und methoden zum nachweis von erkrankungen der brust ATE364089T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74206796A 1996-10-31 1996-10-31

Publications (1)

Publication Number Publication Date
ATE364089T1 true ATE364089T1 (de) 2007-06-15

Family

ID=24983366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97913936T ATE364089T1 (de) 1996-10-31 1997-10-31 Reagenzien und methoden zum nachweis von erkrankungen der brust

Country Status (6)

Country Link
EP (1) EP0939824B1 (de)
JP (2) JP4614472B2 (de)
AT (1) ATE364089T1 (de)
CA (1) CA2269634C (de)
DE (1) DE69737788T2 (de)
WO (1) WO1998018945A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030044859A1 (en) * 1996-08-19 2003-03-06 Henslee Jerry G. Reagents and methods useful for detecting diseases of the breast
US20050202499A1 (en) 1996-10-31 2005-09-15 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
US8034920B2 (en) 1997-10-31 2011-10-11 Abbott Laboratories Nucleic acid primers and probes for detecting breast cells
EP1027444A1 (de) * 1997-10-31 2000-08-16 Abbott Laboratories Reagenzien und verfahren zum nachweis von brustkrankheiten
US6365348B1 (en) 1997-12-24 2002-04-02 Corixa Corporation Compounds for diagnosis of Breast cancer and methods for their use
US6410507B1 (en) 1997-12-24 2002-06-25 Corixa Corporation Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
US6379951B1 (en) * 1997-12-24 2002-04-30 Corixa Corporation Compounds for immunotherapy of breast cancer and methods for their use
US6432707B1 (en) 1997-12-24 2002-08-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6730477B1 (en) 1998-08-04 2004-05-04 Diadexus, Inc. Method of diagnosing, monitoring and staging breast cancer
JP3422776B2 (ja) * 1998-08-04 2003-06-30 ダイアデクスアス・インコーポレーテッド 乳癌を診断、監視、病期決定、造影及び治療する新規な方法
US6737040B1 (en) 1998-08-04 2004-05-18 Diadexus, Inc. Method and antibody for imaging breast cancer
US6756493B1 (en) * 1998-09-01 2004-06-29 Antex Biologics, Inc. Nucleic acid sequence and uses thereof
US6693186B2 (en) * 1998-09-01 2004-02-17 Antex Biologics Inc Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
US6590076B1 (en) * 1999-04-02 2003-07-08 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
ES2343103T3 (es) * 1999-01-21 2010-07-23 Abbott Laboratories Reactivos y metodos utiles para detectar enfermedades de la mama.
US20020034740A1 (en) * 1999-01-21 2002-03-21 Patricia A. Billing-Medel Reagents and methods useful for detecting diseases of the breast
US6316272B1 (en) 1999-03-15 2001-11-13 Eos Biotechnology, Inc. Methods of diagnosis of colorectal cancer and methods of screening for colorectal cancer modulators
US6649342B1 (en) 1999-03-15 2003-11-18 Eos Biotechnology, Inc. Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
US20040141983A1 (en) 1999-03-15 2004-07-22 Protein Design Labs, Inc. Compositions against cancer antigen LIV-1 and uses thereof
EP1159619A2 (de) * 1999-03-15 2001-12-05 EOS Biotechnology, Inc. Verfahren zur diagnose und zum behandeln von brustkrebs
US6762020B1 (en) 1999-03-15 2004-07-13 Protein Design Labs, Inc. Methods of diagnosing breast cancer
AU1777201A (en) * 1999-11-16 2001-05-30 Eos Biotechnology, Inc. Novel methods of diagnosing and determining prognosis of breast cancer, compositions, and methods of screening for breast cancer modulators
US6780586B1 (en) 1999-11-29 2004-08-24 Protein Design Labs, Inc. Methods of diagnosing breast cancer
JP2004503208A (ja) * 2000-02-29 2004-02-05 アボット・ラボラトリーズ 乳房の疾患の検出に有用な試薬および方法
AU2001280443A1 (en) * 2000-06-22 2002-01-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
WO2002021134A2 (en) * 2000-09-08 2002-03-14 Eos Biotechnology, Inc. Methods of diagnosing breast cancer and screening for modulators
WO2004067564A2 (en) 2003-01-29 2004-08-12 Protein Design Labs, Inc. Compositions against cancer antigen liv-1 and uses thereof
JP2008517626A (ja) * 2004-10-28 2008-05-29 アボット・ラボラトリーズ 乳房細胞を検出するための核酸プライマー及びプローブ
GB201009998D0 (en) * 2010-06-15 2010-07-21 Bg Res Cell disruption
MX379481B (es) 2010-12-06 2025-03-11 Seagen Inc Anticuerpos humanizados a liv-1 y uso de los mismos para tratar cancer
KR20220157515A (ko) 2016-03-15 2022-11-29 씨젠 인크. Liv1-adc와 화학요법제를 사용한 병용 요법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2250993B (en) * 1990-11-21 1995-02-15 Inst Nat Sante Rech Med Stromelysin-3 and its application in the diagnosis and treatment of malignant breast cancer
US6114114A (en) * 1992-07-17 2000-09-05 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
CA2175380A1 (en) * 1993-10-29 1995-05-04 Lan Bo Chen A novel tumor marker and novel method of isolating same
WO1995015334A1 (en) * 1993-11-30 1995-06-08 California Pacific Medical Center Research Institute cDNA PROBE FOR BREAST CANCER DIAGNOSIS AND TREATMENT
US5756668A (en) * 1994-11-15 1998-05-26 The Johns Hopkins University School Of Medicine Hypermethylated in cancer polypeptide, HIC-1

Also Published As

Publication number Publication date
DE69737788T2 (de) 2008-03-13
EP0939824B1 (de) 2007-06-06
WO1998018945A1 (en) 1998-05-07
JP2010075188A (ja) 2010-04-08
DE69737788D1 (de) 2007-07-19
CA2269634C (en) 2010-08-17
JP4614472B2 (ja) 2011-01-19
EP0939824A1 (de) 1999-09-08
CA2269634A1 (en) 1998-05-07
JP2001503980A (ja) 2001-03-27

Similar Documents

Publication Publication Date Title
ATE364089T1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
WO2000056352A3 (en) Reagents and methods useful for detecting diseases of the prostate
DE69833572D1 (de) Verfahren zur bestimmung des metastasierungspotentials unter verwendung des asp1 gens
ATE403001T1 (de) Antigenbindungsfragmente die spezifisch krebszellen nachweisen, nukleotide die für diese fragmente kodieren, und deren verwendung zur vorbeugung und zum nachweis von krebs
CO4870792A1 (es) Compuestos y conjunto de medios de diagnostico para detectar y vigilar la progresion de cancer de prostata
CY1105446T1 (el) Διαγνωση και θepαπεια διαταραχων που συνδεονται με aur1 και aur2
DE60033555D1 (de) Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden
ATE463508T1 (de) Reagentien und verfahren zur erkennung von erkrankungen der brust
CA2395729A1 (en) NUCLEIC ACIDS, PROTEINS AND ANTIBODIES
WO2004037999A3 (en) A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
PT991421E (pt) Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa
DE60137264D1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
DK0757723T3 (da) Genetiske ændringer, der korrelerer med lungecarcinoma
ATE386117T1 (de) Prostattumor polynukleotid- und antigenzusammensetzungen
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
ATE320006T1 (de) Methode zum nachweis von zell-apoptose
DK0968421T3 (da) Diagnose af tidlig gastrisk cancer
ATE332979T1 (de) Detektion von änderungen von tumor-suppressor genen zur diagnose von krebs
DE69739653D1 (de) Reagentia und verfahren zum nachweis von brustkrankheiten
ATE466938T1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
NO982588D0 (no) FremgangsmÕte for diagnose og behandling av plate epizelkarsinom
EA199900775A1 (ru) Быстрый способ диагностики рака
WO2002004952A3 (en) Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
JP2005522228A5 (de)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties